Pays: États-Unis
Langue: anglais
Source: NLM (National Library of Medicine)
SODIUM CHLORIDE (UNII: 451W47IQ8X) (SODIUM CATION - UNII:LYR4M0NH37, CHLORIDE ION - UNII:Q32ZN48698)
Dechra Veterinary Products
INTRAVENOUS
PRESCRIPTION
For use in replacement therapy of sodium, chloride and water which may become depleted in many diseases.
HYPERTONIC SALINE SOLUTION 7.2%, USP is supplied in plastic bags as follows: Storage: Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored in the moisture barrier overwrap at room temperature of (15°C - 30°C) OR (59°F - 86°F). Keep out of reach of children, store between
unapproved drug other
VETIVEX VETERINARY HYPERTONIC- SODIUM CHLORIDE INJECTION, SOLUTION DECHRA VETERINARY PRODUCTS _Disclaimer: This drug has not been found by FDA to be safe and effective, and this_ _labeling has not been approved by FDA. For further information about unapproved_ _drugs, click here._ ---------- VETIVEX HYPERTONIC SALINE SOLUTION 7.2%, USP FOR ANIMAL USE ONLY DESCRIPTION: Veterinary Hypertonic Saline Solution 7.2%, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers for parenteral administration. It contains no antimicrobial agents. Discard unused portion. TABLE 1 HYPERTONIC SALINE SOLUTION 7.2%, USP SIZE (ML) SODIUM CHLORINE (MG/ML) OSMOLARITY (MEQ/L) PH SODIUM (MEQ/L) CHLORIDE (MEQ/L) 1000 7200 2464 (4.5 -7.0) 1232 1232 CLINICAL PHARMACOLOGY: Veterinary Hypertonic saline solutions 7.2%, USP has value as a source of water, electrolytes and calories. INDICATIONS AND USAGE: For use in replacement therapy of sodium, chloride and water which may become depleted in many diseases. WARNINGS: This product contains no preservatives. Use entire contents when first opened. Discard any unused solution. The parenteral administration of Veterinary Hypertonic saline solution 7.2%, USP can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states, or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations of the injections. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injection. In patients with diminished renal function, administration of Veterinary Hypertonic saline solution 7.2%, USP may result in sodium retention. ADVERSE REACTIONS: Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, ex Lire le document complet